Scientific Program

Conference Series Ltd invites all the participants across the globe to attend 12th International Conference on Pulmonology & Respiratory Research Amsterdam, Netherlands.

Day :

  • pulmonology-2021

Session Introduction

K M Shahunja

Institute for Social Science Research, The University of Queensland, Brisbane, Australia

Title: Family, neighbourhood and psychosocial environmental factors and their association with asthma in Australia: a systematic review and meta-analysis
Biography:

K M Shahunja is a physician and clinical researcher. He completed his MBBS degree from Sylhet MAG Osmani Medical College, Bangladesh and Post Graduate Diploma in Paediatrics and Child Health from Imperial College London, UK. Currently he is doing his PhD at The University of Queensland, Australia.Before joining to UQ, he worked for about nine years at an international research organization (www.icddrb.org) in Dhaka, Bangladesh. His main interest of research includes child respiratory and alimentary diseases and malnutrition. So far, he has completed some clinical researches including clinical trials and published number of papers in peer-reviewed journals.

Abstract:

Various associations between different environmental exposures and asthma have been reported in different countries and populations. We aimed to investigate the associations between family, neighbourhood and psychosocial environmental factors and asthma in Australia by conducting a systematic review and meta-analysis. We analysed the primary research studies conducted in Australia across multiple databases, including PubMed, EMBASE and Scopus, and published between 2000 and 2020. The reviews and analyses focused on the overall association of different environmental exposures with the development or exacerbation of asthma-symptoms or asthma-related hospital visits. Quality-effect meta-analysis was done to estimate the pooled odds ratio for different environmental exposures for asthma-symptoms. Among the 4,799 unique published articles found, 46 were included here for systematic review and 28 for meta-analysis. Our review found that psychosocial factors, including low socioeconomic condition, maternal depression, mental stress, ethnicity and discrimination, are associated with asthma-symptoms. Pooled analysis was conducted on family and neighbourhood environmental factors and revealed that environmental tobacco smoking (ETS) (OR 1·69, 95% CI 1·19–2.38), synthetic bedding (OR 1·91, 95% CI 1·48–2·47) and gas heaters (OR 1·40, 95% CI 1·12–1·76) had significant overall associations with asthma-symptoms in Australia. Although the studies were heterogeneous, both systematic review and meta-analysis found several psychosocial and family environmental exposures to be significantly associated with asthma-symptoms. Further study to identify their causal relationship, and modification may reduce asthma-symptoms in the Australian population. 

Biography:

Dr Akhil Paul has completed his MBBS and MD from the prestigious Christian Medical College, Vellore, India. He has been awarded a Fellow by the College of Chest Physicians, USA as well as the Asian Pacific Society of Respirology. He is currently working as the interventional pulmonologist, critical care and sleep medicine consultant in a mission hospital and  he has authored  multiple text books and  referrence guides in Pulmonology. He has published more than 15 scientific articles in indexed journals. He was a core comittee member in preparing the Indian national guidelines in the pleural effusion management

Abstract:

About 20% to 67% of  COVID 19 infected patients who are admitted to the hospitals and 100% of  mechanically ventilated patients suffer from Acute Respiratory Distress Syndrome. Extrinsic Positive Expiratory Pressure can improve the oxygenation by direct and indirect mechanisms, thus reducing the need of medical oxygen. But high-budget and sophisticated machines are required to provide this positive airway pressure, adding on to the treatment cost of the patient and investment expenditure by the healthcare facilities.
We have designed a simple self working device which can provide a positive expiratory pressure. The lower part of this device works with the same principle of a 'Bubble- PEP' device. Thus this device can be considered as a bubble PEP device with a modified interface. We call this device ' SWIPER' device (Self working Water based Instrument for Positive Expiratory pressure by Resistance). We are hereby presenting the results of the pilot study in view of the importance of this device in the current scenario.

Biography:

Diriba Dereje is affiliated from Wollega University, Ethiopia.Diriba Dereje has attended many International and National conferences all over the globe.Diriba Dereje has taken participation in several research projects and published research papers in International journals.

Abstract:

Cardiac and renal disease are the most prevalent chronic non-communicable diseases (CNCD) affecting community in a significant manner. The best and recommended method in halting CNCD is by working on prevention as early as possible. This is only possible if early surrogate markers are identified. As part of stated solution, this study will identify an association between microalbuminuria (early surrogate marker of the renal and cardiac disease) and lung function test among adult in the community.

Mohammed Ghaythan Alkhathami

Prince Sultan Militry College of Health Sciences, Saudi Arabia, Damma Master degree candidte at University of Glasgow, UK, Glasgow

Title: Prevalence and mortality of lung comorbidities among patients with COVID-19: A systematic review and meta-analysis
Biography:

Mohammed has completed his Bacholar at the age of 25 years from Prince Sultan Militry College of Health Sciences, Saudi Arabia, Damma and currenly he is completing his MSc degree at University of Glasgow in critical care of medicin program in Queen Elizabeth University Hospital. He is a licturer at Prince Sultan Militry College of Health Sciences, Saudi Arabia. He has published recently published a paper titled Prevalence and mortality of lung comorbidities among patients with COVID-19: A systematic review and meta-analysis in Lung of India Journal.

Abstract:

COVID-19 infections are seen across all age groups, but they have shown to have a predisposition for the elderly and those with underlying comorbidities. Patients with severe COVID-19 infections and comorbidities are more prone to respiratory distress syndrome, mechanical ventilator use, and ultimately succumb to these complications. Little evidence exists of the prevalence of underlying lung comorbidities among COVID-19 patients and associated mortality. We performed a systematic review of the literature including PubMed (Medline), Embase (Ovid), Google Scholar, and Cochrane Library. The last date for our search was April 29, 2020. We included all original research articles on COVID-19 and calculated prevalence of chronic lung disease patients among COVID-19 patients using random effects model. Further, we assessed for mortality rates among COVID-19 patients associated with these lung comorbidities. The authors identified 29 articles that reported prevalence of chronic lung conditions among COVID-19 patients. Among those, 26 were from China and 3 from the United States. The pooled prevalence of lung comorbidities including asthma, chronic obstructive pulmonary disease (COPD), and lung cancer was 3% (95% confidence interval [CI] = 0%–14%), 2.2% (95% CI = 0.02%–0.03%), and 2.1% (95% CI = 0.00%–0.21%), respectively. Mortality rates associated with these comorbidities was 30% (41/137) for COPD and 19% (7/37) for lung cancer respectively. No mortality rates were reported for patients with asthma. This study offers latest evidence of prevalence of chronic lung conditions among patients with COVID-19. Asthma, followed by COPD and lung cancer, was the most common lung comorbidity associated with COVID-19, while the higher mortality rate was found in COPD. Future studies are needed to assess other lung comorbidities and associated mortality among patients diagnosed with COVID-19.